Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33

Medulloblastoma is the most common malignant tumor that arises from the cerebellum of the central nervous system. Clinically, medulloblastomas are treated by surgery, radiation, and chemotherapy, all of which result in toxicity and morbidity. Recent reports have identified that DDX3, a member of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Tantravedi, Saritha, Vesuna, Farhad, Winnard, Paul T., Martin, Allison, Lim, Michael, Eberhart, Charles G., Berlinicke, Cynthia, Raabe, Eric, van Diest, Paul J., Raman, Venu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171097/
https://www.ncbi.nlm.nih.gov/pubmed/30292066
http://dx.doi.org/10.1016/j.tranon.2018.09.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171097/
https://www.ncbi.nlm.nih.gov/pubmed/30292066
http://dx.doi.org/10.1016/j.tranon.2018.09.002

Ejemplares similares